Midcap outperforms Sensex, Nifty hovers around 10,450; Aurobindo up 4%

Epic Update Aurobindo PharmaEpic Update Aurobindo Pharma

Equity benchmarks remained volatile in late morning deals as investors focussed on corporate earnings after Federal Reserve policy meeting wherein the Chair Janet Yellen hinted rate hike in December.

The 30-share BSE Sensex was up 49.83 points at 33,650.10 and the 50-share NSE Nifty gained 8 points at 10,448.50.

The broader markets continued to outperform benchmarks as the NSE Midcap index was up 0.8 percent and Smallcap gained 1.2 percent. About two shares advanced for every share falling on the NSE.

For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co

Facebook Twitter YouTube Pinterest Linkedin Google+

You may also like:

Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited' width= Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed' width=
Sensex, Nifty rangebound; RBI’s MPC meet outcome awaited Sensex, Nifty continue to be sluggish ahead of RBI policy; Europe mixed
Share Button

About the Author

Epic Research
Epic Research
Epic Research - Investment Adviser is a leading financial services provider with presence in Indian and other global capital markets. Call on - 0731-664-2300